Paid Clinical Trials Great Falls
Discover 93 paid clinical trials in Great Falls, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Enasidenib & Cedazuridine-DecitabineTesting the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06577441
Conditions
Myelodysplastic Syndrome
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Aspiration
Bone Marrow Biopsy
Decitabine and Cedazuridine
Enasidenib
MyeloMATCHComparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06672146
Conditions
Acute Myeloid Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Aspiration
Bone Marrow Biopsy
Decitabine and Cedazuridine
Enasidenib
ImmunotherapyImmunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06498635
Conditions
Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Durvalumab
Patient Observation
Questionnaire Administration
Observational StudyMulti-Institutional Registry for Prostate Cancer Radiosurgery
Sponsor:
RPCR, Inc.
Location:
Code:
NCT01226004
Conditions
Prostate Cancer Early Risk Treated by Radiosurgery
Prostate Cancer Intermediate Risk Treated by Radiosurgery
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
SUI-100ΓäóEvaluating SUI-100Γäó, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence
Sponsor:
Acoustic Wave Cell Therapy, Inc.
Location:
Code:
NCT06862648
Conditions
Stress Urinary Incontinence (SUI)
Eligibility Criteria
Sex: Female
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
Acoustic Stimulation Therapy Device
Sham Acoustic Stimulation Therapy Device
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Radiation TherapyComparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases
Sponsor:
NRG Oncology
Location:
Code:
NCT06745024
Conditions
Metastatic Malignant Neoplasm in the Bone
Metastatic Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Best Practice
Patient Observation
Bone Metastases Treatment
Biospecimen Collection
Questionnaire Administration
RSVpreFA Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Sponsor:
Pfizer
Location:
Code:
NCT06866405
Conditions
RSV Infection
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Accepted
Interventions
RSVpreF
Placebo
CONCURxPMobile Health for Adherence in Breast Cancer Patients
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT06112613
Conditions
Anatomic Stage IV Breast Cancer AJCC v8
Breast Carcinoma
HER2-Negative Breast Carcinoma
Hormone Receptor-Positive Breast Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Electronic Health Record Review
Health Promotion and Education
Health Telemonitoring
Interview
Patient Navigation
Targeted TherapyTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05564377
Conditions
Advanced Malignant Solid Neoplasm
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Locally Advanced Malignant Solid Neoplasm
Malignant Female Reproductive System Neoplasm
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Alpelisib
Binimetinib
Biopsy Procedure
Biospecimen Collection
Bone Marrow Aspiration
Nivolumab & IpilimumabA Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT02339571
Conditions
Stage III Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Echocardiography Test
Ipilimumab
Magnetic Resonance Elastography